ONCOSIL MEDICAL LTD

0.43%

$1.15

Market Cap $21.55M

Healthcare Biotechnology

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Latest Threads

Tag

Subject

OSL

Ann: Appendix 4E and Annual Report

31/08/25

355

31/08/25

Last post maxswell

355

OSL

Ann: Appendix 4G and Corporate Governance Statement

29/08/25

104

29/08/25

Last post

ASX News

104

OSL

Ann: Application for quotation of securities - OSL

22/08/25

154

22/08/25

Last post

ASX News

154

OSL

Ann: Investor Webinar Presentation

19/08/25

2.6K

19/08/25

Last post Garris1234

2.6K

OSL

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

12/08/25

4.4K

12/08/25

Last post float^

4.4K

OSL

Ann: Investor Webinar Invitation

07/08/25

213

07/08/25

Last post

ASX News

213

OSL

Ann: Appointment and Resignation of Company Secretary

23/07/25

448

23/07/25

Last post

ASX News

448

OSL

Ann: Completion of Recruitment in TRIPP-FFX Clinical Trial

23/07/25

1.7K

23/07/25

Last post Gekkowolf

1.7K

See All Discussions

Timeline

Appendix 4G and Corporate Governance Statement
29 Aug 12:37	Share

Appendix 4E and Annual Report
29 Aug 12:32	Share

Application for quotation of securities - OSL
22 Aug 10:30	Share

Investor Webinar Presentation
07 Aug 10:14	Share

Investor Webinar Invitation
07 Aug 10:06	Share

Quarterly Activities/Appendix 4C Cash Flow Report
29 Jul 17:41	Share

Appointment and Resignation of Company Secretary
23 Jul 17:40	Share

Completion of Recruitment in TRIPP-FFX Clinical Trial
23 Jul 08:27	Share

Change in substantial holding from SOL
15 Jul 17:07	Share

Change in substantial holding from PCG
15 Jul 13:44	Share

Change in substantial shareholding from AEF
15 Jul 12:52	Share

Application for quotation of securities - OSL
15 Jul 08:36	Share

Final Director's Interest Notice
11 Jul 14:00	Share

Initial Director's Interest Notice
11 Jul 13:59	Share

OSLOD Options Range of Units and Top 20 Holders
11 Jul 10:45	Share

Application for quotation of securities - OSL
11 Jul 10:45	Share

Application for quotation of securities - OSL
11 Jul 10:44	Share

OncoSil announces appointment of Non-Executive Director
11 Jul 09:44	Share

Proposed issue of securities - OSL
09 Jul 13:48	Share

Update - Proposed issue of securities - OSL
09 Jul 12:35	Share

Update - Proposed issue of securities - OSL
09 Jul 12:29	Share

Results of Meeting
08 Jul 13:03	Share

OSL completes $2 million Share Purchase Plan
07 Jul 17:06	Share

Completion of Recruitment in PANCOSIL Study
04 Jul 08:24	Share

Becoming a substantial shareholder from AEF
26 Jun 11:38	Share

Change of Directors Interest Notice Lel Smits
25 Jun 16:43	Share

Notification of cessation of securities - OSL
19 Jun 17:41	Share

Notification regarding unquoted securities - OSL
19 Jun 10:30	Share

Change in substantial holding from SOL
18 Jun 15:37	Share

Change in substantial holding from PCG
17 Jun 15:27	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.15		Change -0.005(0.43%)		Mkt cap ! $21.55M

Open	High	Low	Value	Volume
$1.14	$1.15	$1.13	$7.346K	6.419K

Buyers (Bids)

No.	Vol.	Price($)
2	3982	$1.10

Sellers (Offers)

Price($)	Vol.	No.
$1.15	1850	2

View Market Depth

No.	Vol.	Price($)
2	3982	1.100
1	101	1.085
3	7768	1.080
2	2500	1.070
1	77	1.065

Price($)	Vol.	No.
1.150	1850	2
1.160	1	1
1.165	3054	2
1.170	3240	1
1.180	6688	2

Last trade - 14.28pm 29/08/2025 (20 minute delay)

OSL (ASX) Chart

ONCOSIL MEDICAL LTD

Latest Threads

Timeline

Featured News

Latest Videos

OncoSil (ASX:OSL) treats first commercial patients in the Middle East and Spain

31 Jan 2023 13:48 (AEDT)

Latest Articles

OncoSil wraps up recruitment for key pancreatic cancer trial

Pancreatic cancer treatment focused OncoSil Medical's (ASX:OSL) shares stayed flat on Friday as the company revealed it had finally...

Oncosil device successfully treats pancreatic cancer in Türkiye

Oncosil Medical Ltd reported the successful reduction in tumor size through the use of its flagship device and chemotherapy.

OncoSil's cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide Hospital in South Australia

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News